conjugation with glutathione of dopamine o-quinone and aminochrome. GST M2-2 Glutathione-Mediated Conjugation of Anticancer Drugs:

After ~36 months More visible brightening and tone evenness for those who respond well, alongside antioxidant/anti-ageing support typically with ongoing maintenance sessions

In this context, buthionine sulfoximine (BSO) is the most popular GSH-depleting agent studied in both preclinical and early clinical trials, but limitation on its availability has led to a search for alternatives [13, 14]

EBM Consult

Pickart creates

Depletion of glutathione by buthionine sulfoximine is cytotoxic for human neuroblastoma cell lines via apoptosis

Consistent use over time allows these benefits to build up and become more noticeable